Medical Foods Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Medical Foods Market Research and Forecast
Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Medical Foods Market Global Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the global medical foods
  market size reached US 23.3 Billion in 2023.
• Medical foods are specialty foods formulated to
  be consumed or administered orally or enterally
  under the supervision of a professional for the
  treatment of diseases and to meet nutritional
  requirements. Their purpose is to provide
  nutrients and metabolic assistance to those
  suffering from certain medical conditions.
• As nutritional supplements, they are rich in
  phenolics, vitamins, and minerals, and have
  antibacterial, antifungal, antiviral,
  antiparasitic, and antitumor properties. The use
  of medical foods is considered to be an effective
  way to treat pain, sleep issues, and cognitive
  difficulties.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/medical-foods-market/re
  questsample

4
Report Description

• Global Medical Foods Market Trends
• The global market is majorly driven by the
  increasing measures taken for the dietary
  management of communicable and non-communicable
  diseases. This can be attributed to the rising
  prevalence of viral infections and numerous
  chronic and neurogenic disorders, such as
  dementia, stroke, and multiple sclerosis. In
  addition to this, the growing geriatric
  population that is susceptible to developing
  these diseases and requires specific dietary
  management is providing an impetus to the market.
  Moreover, the easy availability of naturally
  sourced and organic medical food products via
  online and offline organized retail channels is
  fueling the market growth.
• The market is further propelled by the growing
  health consciousness among the masses, along with
  rising awareness regarding the benefits of
  specialized medical foods. Some of the other
  factors contributing to the market include heavy
  investments in product launch activities by the
  manufacturers, rapid digitization in the
  healthcare sector, inflating disposable income
  levels of the masses and extensive research and
  development (RD) activities.
• Looking forward, the market is anticipated to
  reach a value of US 36.5 Billion by 2032,
  exhibiting a CAGR of 5 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/medical-foods-market

5
Report Segmentation

• Breakup by Product
• Pills
• Powder
• Others
•  
• Breakup by Route of Administration
• Oral
• Enteral
• Breakup by Application
• ADHD
• Depression
• Diabetes
• Cancer
• Alzheimer's Disease
• Metabolic Disorders

6
Report Segmentation

• Others
• Breakup by Distribution Channel
• Supermarkets
• Hospital and Retail Pharmacies
• Online Pharmacies
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Abbott Healthcare Private Limited
• Alfasigma S.p.A.
• Danone S.A.
• Fresenius Kabi AG
• Mead Johnson Company LLC (Reckitt Benckiser)
• Medtrition Inc.
• Meiji Holdings Co. Ltd.
• Metagenics Inc. (Alticor)
• Nestlé S.A.
• Primus Pharmaceuticals Inc.
• Targeted Medical Pharma Inc.
• Victus Inc.

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Medical Foods
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product
• 6.1 Pills
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Powder
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 6.3 Others
• 6.3.1 Market Trends
• 6.3.2 Market Forecast
• 7 Market Breakup by Route of Administration 
       

11
Table of Contents

• 7.1 Oral
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Enteral
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 8 Market Breakup by Application
• 8.1 ADHD
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Depression
• 8.2.1 Market Trends
• 8.2.2 Market Forecast
• 8.3 Diabetes
• 8.3.1 Market Trends
• 8.3.2 Market Forecast
• 8.4 Cancer
• 8.4.1 Market Trends
• 8.4.2 Market Forecast

12
Partial List of Clients
13
Partial List of Clients
14
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

15
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us